Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ASTELLAS PHARMA INC.
07:58aASTELLAS PHARMA INC. : - U.S. FDA Grants Fast Track Designation for ASP0367/MA-0..
AQ
10/20ASTELLAS PHARMA INC. : - New Roxadustat Data in Anemia of Chronic Kidney Disease..
AQ
10/16ASTELLAS PHARMA : to acquire iota Biosciences
AQ
10/15ASTELLAS PHARMA : FibroGen to Present New Efficacy and Safety Analyses from Roxa..
AQ
10/14ASTELLAS PHARMA : to Acquire iota Biosciences
BU
10/13ASTELLAS PHARMA : and Seagen Announce Positive Topline Results from Second Cohor..
AQ
10/09ASTELLAS PHARMA : and LabCentral Announce Golden Ticket Winners, Helping Emergin..
AQ
10/02ASTELLAS PHARMA : Celebrates First-Ever Virtual Day of Service to Help Non-Profi..
AQ
09/30ASTELLAS PHARMA : and MBC BioLabs Announce Golden Ticket Competition to Help Bio..
AQ
09/29ASTELLAS PHARMA : Real-World Evidence Studies Provide Further Insight into Negat..
AQ
09/25ASTELLAS PHARMA : and University of Pittsburgh Announce Research Collaboration f..
AQ
09/24ASTELLAS PHARMA INC. : - Astellas Efforts against the Spread of the Coronavirus ..
AQ
09/24ASTELLAS PHARMA : Collaborates with Two Research Centers at the University of To..
AQ
09/24ASTELLAS PHARMA : and Seattle Genetics Announce PADCEV Significantly Improved Ov..
AQ
09/22ASTELLAS PHARMA : and Seattle Genetics Announce PADCEV Significantly Improved Ov..
PU
08/24ASTELLAS PHARMA INC. : - Science-Based Fitness Service, Fit-eNce
AQ
08/10ASTELLAS PHARMA : Open Innovation Challenge Astellas Rx+ Healthcare Innovation C..
AQ
07/23ASTELLAS PHARMA : is Awarded Grant from the U.S. National Institutes of Health t..
AQ
07/20ASTELLAS PHARMA : Named to FTSE4Good Index Series for Ninth Consecutive Year
AQ
06/17ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
06/09ASTELLAS PHARMA : Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phas..
AQ
06/05ASTELLAS PHARMA : City of Yokohama, and Yokohama City University Developed Scien..
AQ
06/03ASTELLAS PHARMA : Federal Circuit Reverses PTAB Finding Tarceva® Method Of Treat..
AQ
05/28ASTELLAS PHARMA INC. : - FDA Approves VESIcare LS Oral Suspension for Pediatric ..
AQ
05/21ASTELLAS PHARMA INC. : - Notice Regarding Continuation of the Performance-linked..
AQ
05/21ASTELLAS PHARMA : European Medicines Agency Accepts Astellas Marketing Authoriza..
AQ
05/14ASTELLAS PHARMA : Immunomic Therapeutics, Inc. - Maryland's Immunomic Therapeuti..
AQ
04/29ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
04/27ASTELLAS PHARMA : and Harvard Establish Strategic Research Alliance
PU
04/27ASTELLAS PHARMA INC. : - Change of Directors and Organizational Change
AQ
04/21ASTELLAS PHARMA : Announces Acquisition of Nanna
AQ
04/10ASTELLAS PHARMA : Announces Acceptance of XOSPATA for Regulatory Review in China..
AQ
04/06ASTELLAS PHARMA : and BANDAI NAMCO Entertainment Enter into Agreement to Co-Deve..
AQ
04/05ASTELLAS PHARMA : Three Astellas Research and Production Facilities in Japan Ado..
PU
03/30ASTELLAS PHARMA : Launches its Corporate Website's Science Section
PU
03/24CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop ..
AQ
03/23ASTELLAS PHARMA : CytomX Therapeutics and Astellas Announce Strategic Collaborat..
PU
03/18ASTELLAS PHARMA : Gifu University and Astellas establish a Research Course on Ph..
AQ
02/27ASTELLAS PHARMA : Notice Regarding the Performance-linked Stock Compensation Sch..
PU
02/20Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation fo..
AQ
02/19ASTELLAS PHARMA : and Seattle Genetics Receive FDA Breakthrough Therapy Designat..
PU
02/12ASTELLAS PHARMA : XTANDI Demonstrates Significant Improvement in Overall Surviva..
AQ
02/11SEATTLE GENETICS : and Astellas Announce Updated Results from Phase 1b/2 Trial o..
AQ
02/06ASTELLAS PHARMA : Announces Management Structure
AQ
02/03ASTELLAS PHARMA : Announces Completion of Acquisition of Own Shares, and Cancell..
PU
01/31ASTELLAS PHARMA : Submits Supplemental New Drug Application for Approval of Evre..
AQ
01/31ASTELLAS PHARMA : Will Renew Its Corporate Website's Innovation Section
PU
01/23ASTELLAS PHARMA : Amgen astellas biopharma to become a wholly owned amgen affili..
PU
01/17ASTELLAS PHARMA : Announces Construction of New Manufacturing Facility for Activ..
AQ
01/09ASTELLAS PHARMA INC. : - U.S. FDA Approves Supplemental New Drug Application for..
AQ
01/05ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
PU
2019ASTELLAS PHARMA : Strengthens Immuno-oncology Pipeline with Acquisition of Xypho..
AQ
2019ASTELLAS PHARMA : Strengthens Immuno-oncology Pipeline with Acquisition of Xypho..
PU
2019ASTELLAS PHARMA INC. : - FDA Grants Accelerated Approval to Astellas and Seattle..
AQ
2019PFIZER INC. : - XTANDI Approved by U.S. FDA for the Treatment of Metastatic Cast..
AQ
2019ASTELLAS PHARMA : Announces Key Leadership Promotions in Human Resources, Legal
AQ
2019ASTELLAS PHARMA : Presents New Data on XOSPATA in FLT3 Mutation-Positive Relapse..
AQ
2019Seattle Genetics and Astellas Announce Clinical Trial Collaboration with Merc..
AQ
2019ASTELLAS PHARMA : to buy U.S. biotech firm for $3 bil. to boost gene therapy
AQ
2019ASTELLAS PHARMA : ACQUISITION OF AUDENTES - Establishing a leading position in g..
PU
2019ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
PU
2019ASTELLAS PHARMA : Announces the Approval of XTANDI by the China National Medical..
AQ
2019ASTELLAS PHARMA : and Welldoc Enter into Strategic Alliance for Digital Therapeu..
AQ
2019ASTELLAS PHARMA : and Welldoc Enter into Strategic Alliance for Digital Therapeu..
PU
2019ASTELLAS PHARMA : New England Journal of Medicine Publishes Results from Astella..
AQ
2019ASTELLAS PHARMA : Announces Acquisition of Own Shares and Cancellation of Treasu..
PU
2019ASTELLAS PHARMA : New England Journal of Medicine Publishes Results from Astella..
PU
2019ASTELLAS PHARMA : Pandion and Astellas Announce Collaboration to Deliver Pancrea..
BU
2019Main events scheduled for Thursday, Oct. 31
AQ
2019ASTELLAS PHARMA : Oncology Announces Grand Prize Winner of 2019 C3 Prize to Impr..
AQ
2019ASTELLAS PHARMA : European Commission Approves Astellas XOSPATA as a Monotherapy..
AQ
2019ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for the Dev..
PU
2019ASTELLAS PHARMA : European Commission Approves Astellas' XOSPATA™ (gilteri..
PU
2019ASTELLAS PHARMA : Announces Personnel Changes
PU
2019ASTELLAS PHARMA : Transfers Three Products in Asia Region to Daiichi Sankyo
PU
1  2  3  4  5  6  7Next
Upcoming event on ASTELLAS PHARMA INC.